Lymperopoulos A - Search Results

1

Clinical pharmacogenomics of carvedilol: the stereo-selective metabolism angle.

Parker BM, Rogers SL, Lymperopoulos A. Parker BM, et al. Among authors: lymperopoulos a. Pharmacogenomics. 2018 Sep 1;19(14):1089-1093. doi: 10.2217/pgs-2018-0115. Epub 2018 Aug 8. Pharmacogenomics. 2018. PMID: 30086658 Free article. No abstract available.

2

Pharmacogenomics of adrenoceptors.

Flordellis C, Paris H, Karabinis A, Lymperopoulos A. Flordellis C, et al. Among authors: lymperopoulos a. Pharmacogenomics. 2004 Oct;5(7):803-17. doi: 10.1517/14622416.5.7.803. Pharmacogenomics. 2004. PMID: 15469404 Review.

3

Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknown.

Lymperopoulos A, Bathgate A. Lymperopoulos A, et al. Pharmacogenomics. 2012 Feb;13(3):323-41. doi: 10.2217/pgs.11.178. Pharmacogenomics. 2012. PMID: 22304582 Review.

4

β1- and α2C-adrenergic receptor polymorphisms and the antiarrhythmic effect of bucindolol in heart failure with reduced ejection fraction.

Lymperopoulos A, Negussie S, Walklett K. Lymperopoulos A, et al. Pharmacogenomics. 2013 Oct;14(13):1545-9. doi: 10.2217/pgs.13.137. Pharmacogenomics. 2013. PMID: 24088125 No abstract available.

5

Pharmacogenomics of heart failure.

Lymperopoulos A, French F. Lymperopoulos A, et al. Methods Mol Biol. 2014;1175:245-57. doi: 10.1007/978-1-4939-0956-8_10. Methods Mol Biol. 2014. PMID: 25150872

6

Pharmacogenetics of cardiac inotropy.

Lymperopoulos A, Garcia D, Walklett K. Lymperopoulos A, et al. Pharmacogenomics. 2014 Nov;15(14):1807-1821. doi: 10.2217/pgs.14.120. Pharmacogenomics. 2014. PMID: 25493572

7

β1-adrenoceptor Arg389Gly polymorphism and heart disease: marching toward clinical practice integration.

McCrink KA, Lymperopoulos A. McCrink KA, et al. Among authors: lymperopoulos a. Pharmacogenomics. 2015;16(10):1035-8. doi: 10.2217/pgs.15.104. Epub 2015 Aug 28. Pharmacogenomics. 2015. PMID: 26314313 Free article. No abstract available.

8

Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol.

Lymperopoulos A, McCrink KA, Brill A. Lymperopoulos A, et al. Curr Drug Metab. 2015;17(1):30-6. doi: 10.2174/1389200217666151105125425. Curr Drug Metab. 2015. PMID: 26537419 Review.

9

β₁-adrenoceptor Arg389Gly polymorphism confers differential β-arrestin-binding tropism in cardiac myocytes.

McCrink KA, Brill A, Jafferjee M, Valero TR, Marrero C, Rodriguez MM, Hale GM, Lymperopoulos A. McCrink KA, et al. Among authors: lymperopoulos a. Pharmacogenomics. 2016 Oct;17(15):1611-1620. doi: 10.2217/pgs-2016-0094. Epub 2016 Sep 19. Pharmacogenomics. 2016. PMID: 27643874

10

Biased Agonism/Antagonism of Cardiovascular GPCRs for Heart Failure Therapy.

Desimine VL, McCrink KA, Parker BM, Wertz SL, Maning J, Lymperopoulos A. Desimine VL, et al. Among authors: lymperopoulos a. Int Rev Cell Mol Biol. 2018;339:41-61. doi: 10.1016/bs.ircmb.2018.02.007. Epub 2018 Mar 26. Int Rev Cell Mol Biol. 2018. PMID: 29776604 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page